Interview Study Seeks Caregivers of Children/Adolescents with Angelman Syndrome.
The purpose of this interview study is to gather information about caregivers’ experiences with Angelman syndrome (AS). Caregivers of patients aged 5 to 17
Genomic Imprinting Does Not Reduce the Dosage of UBE3A in Neurons
Summary by Allyson Berent, DVM, DACVIM Angelman syndrome (AS) is caused by loss of the maternally inherited copy of the UBE3A gene. Like most genes, the UBE3
Quantitative Measurement of Communication Ability in Children with Angelman Syndrome
Summary by Allyson Berent, DVM, DACVIM Individuals affected with Angelman syndrome (AS) are known to have limited functional speech and are typically able to
Private Dinner with Colin Farrell and Dr. Edwin Weeber
[wpv-autop]In Partnership With Vivint Gives Back, FAST Announces The Mother Of All Contests.[/wpv-autop][wpv-autop] Starting today, February 1, 2017 and runn
Ganaxalone As Potential Therapeutic For Angelman Syndrome
[wpv-autop]Effects of the synthetic neurosteroid ganaxolone on seizure activity and behavioral deficits in an Angelman syndrome mouse model.[/wpv-autop][wpv-
FAST US and FAST AU Announce Joint Funding To Dr. Arthur Beaudet To Generate Mouse Lines Expressing Human UBE3A Antisense
“Of all the childhood genetic neurologic disorders of the brain, Angelman syndrome may be the single best candidate for developing a definitive treatment (
FAST Summit Live stream
Watch all the news and updates from the Science Summit 9-5pm Friday, December 2 (CST) and
the Education Summit on Saturday December 3, 9-4PM.
Gene Therapy 101
written by Allyson Berent, DVM DACVIM When we refer to gene therapy in Angelman Syndrome (AS), we are typically referring to a “viral delivery” or “vir
UC DAVIS Researchers hone in on Angelman Syndrome Treatment
FAST (Foundation for Angelman Syndrome Therapeutics) has funded two research labs at the University of California, Davis (UC Davis) to further investigation
5.8 Million Steps Closer To A Cure
How FAST Is Changing The Landscape Of Angelman Research When you set out to cure an ‘incurable’ genetic disorder, you need three things: a comprehensive,